APA (7th ed.) Citation

Anna Egorova, Alexander Selutin, Marianna Maretina, Sergei Selkov, Vladislav Baranov, & Anton Kiselev. (2020). Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells. MDPI AG.

Chicago Style (17th ed.) Citation

Anna Egorova, Alexander Selutin, Marianna Maretina, Sergei Selkov, Vladislav Baranov, and Anton Kiselev. Characterization of IRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells. MDPI AG, 2020.

MLA (9th ed.) Citation

Anna Egorova, et al. Characterization of IRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells. MDPI AG, 2020.